Johnson & Johnson (JNJ) said it has submitted an application to the FDA for its therapy candidate TAR-200 for the treatment of a certain type of bladder cancer. Read more here.
Communities exposed to drinking water contaminated with manufactured chemicals known as per- and polyfluoroalkyl substances (PFAS) experience up to a ...